News

06-11-2020
How to avoid a showdown within the healthcare sector

At Copenhagen Economics, we see a showdown within the healthcare sector. We see a growing global gap between healthcare systems’ ambition to curb rising costs and pharma companies’ ambition to secure prices anchored in product value.

How can we avoid the showdown?
See our Managing Partner Christian Jervelund’s take in the video below.

Watch the video here

For further information, please contact Managing Partner Christian Jervelund

02-11-2020
Cezar Miu joins Copenhagen Economics

Copenhagen Economics is proud to announce the hiring of Cezar Miu as an Intern. He joins our Brussels office.

Cezar has a MBA in Business Information Management from Katholieke Universiteit Leuven in Belgium. He has previously worked as a Software Asset Management Consultant at Deloitte in Brussels and most recently he worked as a Pricing Specialist for UPS in Belgium as well.

29-10-2020
Serafino Abate moderates debate on fixed mobile convergence

On Thursday 5 November, the Florence School of Regulation - FSR Energy is hosting a debate on fixed mobile convergence as part of their series on 5G in the time of pandemic.

Our Senior Associate Serafino Abate will moderate this debate.

The convergence of fixed and mobile communications is a relevant trend in the development of the EU system of communications in the long run. The complementarity of the two technologies is likely to be essential to progress further with 5G.

However, there are limits of different kinds – geographic, economic, technical and regulatory – on how much the existing fixed infrastructure can be repurposed.

Learn more and sign up

For further information, please contact Senior Associate Serafino Abate

29-10-2020
New study: THE NET COST OF FLASH GLUCOSE MONITORING IS MUCH LOWER THAN ITS UPFRONT COST IN NORWAY  

Flash Glucose Monitoring is a new and superior way for people with diabetes to monitor their blood glucose level, which is already available to people with type I diabetes in Norway. In contrast, the most common way for people with type II to monitor their blood glucose level is the so-called finger pricking method.

In our recent study, we find that the net cost of Flash Glucose Monitoring for people with type II diabetes in Norway is much lower than its upfront cost due to a reduction in risk of diabetes related complications such as hypoglycaemia.

Learn more about the study

For further information, please contact Senior Economist Søren Brenøe

28-10-2020
Christian Jervelund speaks at World Orphan Drug Congress Europe

In view of the European Commission’s forthcoming review of the Orphan Regulation, the World Orphan Drug Congress host a workshop on the key issues, which will be addressed in the forthcoming review.

The workshop is designed so that it offers the opportunity for the European Commission and relevant stakeholders to explore what revisions are needed for the legislation to appropriately incentivise the development and availability of products for people living with rare diseases.

Our Managing Partner, Christian Jervelund, participates in the workshop, introducing initial study findings.

The workshop takes place virtually on Monday 2 November from 14.00 – 17.00.

Learn more about the workshop and sign up

For further information, please contact Managing Partner Christian Jervelund